Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient
申请人:THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY—ACADEMIC COOPERATION FOUNDATION
公开号:US10369121B2
公开(公告)日:2019-08-06
The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-α, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.
本发明涉及一种能够有效预防和治疗免疫性疾病的双胍类衍生物化合物。根据本发明的双胍基衍生物化合物可抑制炎性细胞因子 IL-17 和 TNF-α的生成,提高具有免疫调节功能的调节性 T 细胞的活性,并在免疫疾病动物模型中表现出良好的治疗效果。因此,该双胍基衍生物化合物可有效用作免疫抑制剂或药物组合物,能够预防或治疗各种免疫疾病,例如由免疫反应失调引起的自身免疫性疾病、炎症性疾病和移植排斥反应。